TrialHaematologica2015

Characteristics and management of rash following lenalidomide and rituximab in patients with untreated indolent non-Hodgkin lymphoma.

Nathan H Fowler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.